Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

Oblique Therapeutics

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Göteborg, Vastra Gotaland, Sweden Founded 2015 1-10 employees For Profit

Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer.

Oblique Therapeutics on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

Total Funding
$3.94M
Funding Rounds
2
Last Funding
Acquisitions
0
Monthly Visits
Contacts
2
Patents
22
8 trademarks

About Oblique Therapeutics

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
3
Patents granted
22
Trademarks
8
Top patent class
Organic Chemistry
IT spend
$143.43K

Company Info

Founded
2015
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
Founders
2
News articles
23
HQ
Göteborg, Vastra Gotaland, Sweden
Region
European Union (EU), Nordic Countries, Scandinavia

Signals & Scores

Heat score
High
Growth score
High
Trend (7d)
-0.4
Trend (30d)
9.6
Trend (90d)
9.8
Last leadership hire
May 8, 2026

Oblique Therapeutics Funding Rounds

2 results
Upgrade to Pro to view this datasetUpgrade
Organization NameFunding TypeLead Investor NamesOrg Hq Country
1–2 of 2Show
Page 1 / 1

Oblique Therapeutics Key People

Chief Medical Officer
Chief Business Officer
Chief Development Officer
CSO, Founder and Board member
Chief Financial Officer
Program Director
Chief Executive Officer
Chief Technical Officer
2
professional contacts at Oblique Therapeutics
Contact execs at Oblique Therapeutics

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

Recent News related to Oblique Therapeutics

Loading news…

FAQs about Oblique Therapeutics

People who checked this page also checked these

Browse the full Acquirezy directory.